Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer News and commentary from the endocrinology world Oct 31, 2023
Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? News and commentary from the endocrinology world Oct 24, 2023
Certain Factors Predict Weight Regain After Big Losses But even "regainers" still kept off most of the weight Oct 17, 2023
Regaining Weight After Bariatric Surgery Did Not Lead to Excess Mortality Weight regainers had a similar incidence of mortality as weight-loss maintainers Oct 17, 2023
Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
Mental Health Warning Signs in Latinx Kids Tied to Cardiometabolic Risks Signs of depression, anxiety in middle school linked with troubles by high school Oct 16, 2023
Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test News and commentary from the endocrinology world Oct 10, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits News and commentary from the endocrinology world Sep 26, 2023
Over One-Third of Adults in 22 States Have Obesity, CDC Says No states hit this threshold a decade ago Sep 22, 2023
Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? News and commentary from the endocrinology world Sep 19, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Endocrine Disruptors in Paper Straws; Wegovy's CV Benefit; Stroke and Infertility Tx News and commentary from the endocrinology world Sep 05, 2023
Insulin Calculator Cleared; Twice-Rejected Diabetes Drug; Ozempic for Alcohol Use? News and commentary from the endocrinology world Aug 29, 2023
Testosterone Loss in Older Men: Factors Beyond Age in the Mix Several lifestyle, health factors associated with declining levels Aug 28, 2023
Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limits News and commentary from the endocrinology world Aug 15, 2023
Trial Supports GLP-1 After Underwhelming Metabolic Surgery Helped more patients achieve clinically significant weight loss Jul 27, 2023
Yet Another Injectable Combo Achieves Near 15% Weight Loss in Trial But GI side effects higher than other comparable anti-obesity agents Jun 27, 2023
High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
Breast Cancer Drugs May Weaken Effects of Weight-Loss Drugs Survivors on aromatase inhibitors lost significantly less weight Jun 18, 2023
BMI vs Body Fat Percentage: Measures Conflict When Classifying Obesity Clinicians should not rely solely on BMI for measuring obesity, researcher says Jun 16, 2023
Oral Semaglutide Sheds Pounds; USPSTF Taking Obesity Comments; Plant Extract for T2D News and commentary from the endocrinology world May 23, 2023
Quarter of Wegovy-Treated Teens With Obesity Return to Normal Weight Overall, nearly half dropped below threshold for obesity May 17, 2023
Obesity Drug's Mid-Stage Win; Endocrine Disease Disparities; Chewing Away Diabetes? News and commentary from the endocrinology world May 16, 2023
Is Electrical Duodenal Resurfacing the Next Big Thing for T2D and Obesity? Small trials show big boost in insulin sensitivity, plus weight loss May 07, 2023
Insulin Resistance Risk Much Higher for Kids With Obesity Waist-to-hip-ratio, waist circumference can aid in predicting IR, researcher says May 07, 2023
Patients Shed 15% of Body Weight With Tirzepatide, Drugmaker Says With findings from SURMOUNT-2, Eli Lilly plans to finish FDA submission Apr 27, 2023
Weight Loss Giants Going Head-to-Head; FDA OKs Omnipod GO; GLP-1 Drugs for Wolfram? News and commentary from the endocrinology world Apr 25, 2023
New Reader for FreeStyle Libre 3; COVID Bumps Diabetes Risk; Tepezza Label Expanded News and commentary from the endocrinology world Apr 18, 2023
'Green' Mediterranean Diet Linked to Aortic Stiffness Reversal All healthy diets helped, but one had the biggest impact in post hoc trial analysis Apr 17, 2023
Higher Rybelsus Doses More Effective; Insulin Cap for All? Win for GLP-1/GIP Drug News and commentary from the endocrinology world Mar 28, 2023
Can Mothers Pass Obesity on to Daughters? Approaches to addressing body weight and composition should start early in life, researcher says Mar 21, 2023
Ozempic Back on Shelves; More Positive Fezolinetant Data; Caffeine Cuts Fat? News and commentary from the endocrinology world Mar 21, 2023
Dexcom G7 CGM Covered by Medicare; T1D Off-Label Drug Use; Another Tepezza Lawsuit News and commentary from the endocrinology world Feb 21, 2023
Rybelsus Now OK'd in First Line; Menopause Before Transition; Novel T2D Drug Flops News and commentary from the endocrinology world Jan 17, 2023